Ads
related to: pfizer biontech vaccine stock- Raising Capital
A new playbook for a new era
in biotech.
- Biotech Balancing Act
Biotech juggles innovation,
competition, policy, and funding.
- Biotech Election Impact
How will biotech navigate election
impacts on pricing & patent rights?
- About Us
RBC's History, Culture & Values
Learn More
- Biotech Insights
Biotech bolsters the market but
tailwinds for services and HCIT.
- Insights
Get Insights From RBC Experts on
Industry Sectors & Future Outlooks
- Raising Capital
Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoInstead, the Street is closely watching the adult RSV vaccine, which hit the market at the same time...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 3 days agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 4 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 5 days agoThe reason Novavax's stock chart looks so wild has to do with its promise and missed opportunity...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoThe company is a leader in the neuroscience space. Neurocrine recently asked the Food and Drug...
Cracking The Code: Understanding Analyst Reviews For BioNTech - BioNTech (NASDAQ:BNTX)
Benzinga· 7 days agoDebt Management: BioNTech's debt-to-equity ratio is below the industry average at 0.01 , reflecting a lower dependency on debt financing and a more conservative financial.
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 4 days agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19:...
Benzinga· 5 days agoElon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of...
